Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Pfizer to cut around 2 percent of jobs through early next year

Published 10/17/2018, 01:22 PM
Updated 10/17/2018, 01:22 PM
© Reuters. FILE PHOTO: A man walks past Pfizer's world headquarters in New York

© Reuters. FILE PHOTO: A man walks past Pfizer's world headquarters in New York

NEW YORK (Reuters) - U.S. drugmaker Pfizer Inc (N:PFE) plans to reduce its global headcount by around 2 percent through voluntary retirements and layoffs this year and early next year, as it looks to streamline its corporate structure and eliminate some managerial roles and responsibilities.

Pfizer has around 90,000 employees worldwide.

Pfizer spokeswoman Sally Beatty said the job cuts were "about creating a simpler, more efficient structure and not achieving cost savings."

The job cuts were originally reported by CNBC.

The move follows the announcement earlier this month that Chief Operating Officer Albert Bourla would succeed Ian Read as chief executive in January. The company also added new responsibilities for many of its top managers and hired a new chief digital officer.

© Reuters. FILE PHOTO: A man walks past Pfizer's world headquarters in New York

Shares of Pfizer were up 1.8 percent at $44.70 in early afternoon trading on the New York Stock Exchange. Its shares are up around 20 percent this year, outperforming the Standard & Poors 500 index, which is up about 4 percent over the same period.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.